Synairgen has specialised scientific research and clinical teams dedicated to drug discovery and development in asthma, COPD and other respiratory diseases. Their main activities are summarised opposite:



  • Advanced human in vitro models generated from the BioBank samples, including use of virus infection models (experienced in use of rhinovirus, RSV, influenza etc.)

  • Lung biomarker validation and assessment

  • Application of human tissue models for:
    • Target discovery
    • Target validity
    • Support clinical activity


  • Extensive BioBank of relevant tissue, cells, blood and airway secretions from volunteers (both diseased and healthy)

  • Phase I & II clinical trial capability

  • Expertise in common cold virus challenge studies in subjects with respiratory disease


For more detailed information please go to Technology and Programmes